Lipella Pharmaceuticals Inc.
LIPOOTCHealthcare● Active
$0.10
$-0.01(-4.76%)
Market Cap$462084
P/E Ratio—
52W High$3.17
52W Low$0.02
Lipella Pharmaceuticals Inc.（LIPO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LIPO · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.54M | $0.45M | $0.18M | $0.26M | $0.96M |
| Cost of Revenue | $3.61M | $3.04M | $2.55M | $1.46M | $0.98M |
| Gross Profit | ($3.08M) | ($2.59M) | ($2.36M) | ($1.20M) | ($0.01M) |
| Gross Margin %(computed) | -573.65% | -575.87% | — | -461.71% | -1.48% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $2.55M | $1.46M | $0.98M |
| G&A Expenses | $2.00M | $2.16M | $0.23M | $0.72M | $0.04M |
| Total Operating Expenses | $2.00M | $2.16M | $0.23M | $0.72M | $0.04M |
| Operating Income | ($5.08M) | ($4.75M) | ($2.59M) | ($1.92M) | ($0.06M) |
| Operating Margin %(computed) | -947.23% | — | — | -738.71% | -5.91% |
| Interest Income | $0.06M | $0.14M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.01M | $0.01M | $0.01M | $0.01M |
| Income Before Tax | ($5.02M) | ($4.62M) | ($2.60M) | ($1.87M) | ($0.06M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($5.02M) | ($4.62M) | ($2.60M) | ($1.87M) | ($0.06M) |
| Net Margin %(computed) | -935.25% | — | — | -719.30% | -6.41% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.79 | $-6.16 | $-5.12 | $-4.00 | $-0.23 |
| Wtd Avg Shares | 1.05M | 0.75M | 0.51M | 0.47M | 0.27M |
| EBITDA | ($5.01M) | ($4.61M) | ($2.59M) | ($1.86M) | ($0.05M) |
| EBITDA Margin %(computed) | -934.71% | — | — | -716.66% | -5.58% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Lipella Pharmaceuticals Inc.
关于Lipella Pharmaceuticals Inc.（LIPO）损益表
Lipella Pharmaceuticals Inc.（LIPO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，LIPO实现营收$0.00B，毛利润($0.00B)（毛利率-573.65%），净利润($0.01B)（净利率-935.25%）。
常见问题
LIPO · 4 问Lipella Pharmaceuticals Inc.（LIPO）2024财年营收为$0.00B，同比up19.3%。
LIPO revenueLIPO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09